ICAM1 and metabolic syndrome: Irisin inhibits the levels of cell adhesion molecules (CAMs), such as intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion protein 1 (VCAM-1), and E-selectin, which are elevated by dyslipidemia and reduces leukocyte and monocyte adhesion to the arterial wall surface [25].